Topical Treatment of Eczema with Triamcinolone Acetonide Benzoyl-β-Amino-Isobutyrate: A Double-Blind Comparison with Betamethasone Dipropionate

1977 ◽  
Vol 5 (3) ◽  
pp. 207-212
Author(s):  
F E Roessei

The results are reported of a double-blind study of the topical efficacy of triamcinolone acetonide benzoyl-β-amino-isobutyrate (TBI), in 21 patients with symmetrically paired lesions of acute eczema. The effects were compared with those of betamethasone dipropionate. On the indication chosen, the two corticosteroids were equally efficacious; tolerance, also, was the same for both substances.

1982 ◽  
Vol 10 (1) ◽  
pp. 22-27 ◽  
Author(s):  
Eugene Leibsohn

In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic, were treated with either diflorasone diacetate ointment 0.05% or betamethasone dipropionate ointment 0.05% twice a day for 3 weeks. Clinical evaluations were based on overall improvement and improvement in signs or symptoms of erythema, oedema, lichenification, induration, scaliness, excoriations, pruritus, and soreness. Results showed that both medications were effective and when patients were categorized according to initial lesion severity, no statistically significant differences existed between treatment groups.


1984 ◽  
Vol 12 (3) ◽  
pp. 170-173 ◽  
Author(s):  
Lars Hillström

A new preparation for treatment of psoriasis of the scalp, containing desoxymethasone 0·25%, salicylic acid 1% and polyol-fatty esters in ethanolic solution (Ibaril®) was tested in patients with psoriasis of the scalp. In a double-blind study comprising forty patients there was a significant difference in favour of this solution in comparison with betamethasone valerate solution, 0·1% (Betnovat®) after 2 weeks of treatment.


Dermatology ◽  
1993 ◽  
Vol 187 (4) ◽  
pp. 263-267 ◽  
Author(s):  
C. Schmied ◽  
P.-A. Piletta ◽  
J.-H. Saurat

Sign in / Sign up

Export Citation Format

Share Document